GELS

Gelteq Ltd

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 100%
Negative

Neutral
GlobeNewsWire
3 days ago
Gelteq Furthers Asia Presence Through Partnership with Hong Kong Flag Football Program
Collaboration Combines Growing International Interest in Gelteq's Sports Science Technology with Rising Interest in Flag Football Ahead of 2028 Summer Olympic Games Debut in Los Angeles Collaboration Combines Growing International Interest in Gelteq's Sports Science Technology with Rising Interest in Flag Football Ahead of 2028 Summer Olympic Games Debut in Los Angeles
Gelteq Furthers Asia Presence Through Partnership with Hong Kong Flag Football Program
Neutral
GlobeNewsWire
10 days ago
Gelteq Signs Three Year Sales Agreement with Shenzhen Mana Health Management Co. Strengthening Gelteq's Nutritional Product Expansion into China
Agreement includes minimum annual order commitments totalling approximately USD $1.3 million Agreement includes minimum annual order commitments totalling approximately USD $1.3 million
Gelteq Signs Three Year Sales Agreement with Shenzhen Mana Health Management Co. Strengthening Gelteq's Nutritional Product Expansion into China
Neutral
GlobeNewsWire
14 days ago
Gelteq Preclinical Study Demonstrates Enhanced Oral Delivery of Oil-Soluble and Poorly Soluble Drugs Using Its Gel-Based Platform
MELBOURNE, Australia, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”), a clinical and science-based developer of advanced gel-based oral delivery systems, today announced preclinical findings demonstrating the effectiveness, flexibility, and safety profile of its proprietary gel platform. The results address a major challenge in pharmaceutical development and demonstrate that Gelteq's technology can enhance the oral delivery of oil-soluble and poorly soluble drugs.
Gelteq Preclinical Study Demonstrates Enhanced Oral Delivery of Oil-Soluble and Poorly Soluble Drugs Using Its Gel-Based Platform
Neutral
GlobeNewsWire
17 days ago
Gelteq to Present at Investor Summit Virtual on December 9, 2025
MELBOURNE, Australia, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (Nasdaq: GELS) (“Gelteq”) today announced that Nathan Givoni, its Chief Executive Officer, will present at the Q4 Investor Summit Virtual on December 9, 2025, where he will share updates on Gelteq's growth strategy, market positioning, and upcoming catalysts. The Investor Summit is an exclusive virtual event connecting investors with disruptive small and microcap companies.
Gelteq to Present at Investor Summit Virtual on December 9, 2025
Neutral
GlobeNewsWire
25 days ago
Gelteq Announces Positive Preclinical Results Demonstrating Enhanced Bioavailability Using Its Proprietary Gel-Based Drug Delivery Platform
Findings Anticipated to Unlock Broad New Commercial Opportunities Across Water-Soluble Drug Classes Findings Anticipated to Unlock Broad New Commercial Opportunities Across Water-Soluble Drug Classes
Gelteq Announces Positive Preclinical Results Demonstrating Enhanced Bioavailability Using Its Proprietary Gel-Based Drug Delivery Platform
Neutral
Accesswire
1 month ago
Healthy Extracts Reports Record Q3 2025, with Revenue up 23%
LAS VEGAS, NV / ACCESS Newswire / November 14, 2025 / Healthy Extracts Inc. (OTCQB:HYEX), a leader in plant-based nutraceutical innovations, reported results for the third quarter and nine months ended September 30, 2025. All comparisons are to the same year-ago period unless otherwise noted.
Healthy Extracts Reports Record Q3 2025, with Revenue up 23%
Neutral
Accesswire
1 month ago
Nutraceutical Technology Leader, Healthy Extracts, Invited to Present at the Trickle Research Microcap Conference on November 13, 2025
LAS VEGAS, NV / ACCESS Newswire / November 11, 2025 / Healthy Extracts Inc. (OTCQB:HYEX), a leader in science-based nutraceuticals and oral delivery technology for transformational health and longevity, has been invited to present at the annual fall Trickle Research Microcap Conference being held at the Topgolf Centennial in Centennial, Colorado on November 13, 2025. On the day of the event, a live stream of the conference can be viewed here.
Nutraceutical Technology Leader, Healthy Extracts, Invited to Present at the Trickle Research Microcap Conference on November 13, 2025
Neutral
GlobeNewsWire
3 months ago
Gelteq Technology Powers U.S. Product Launches of its Nutraceutical Products for Partner
MELBOURNE, Australia, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company,” NASDAQ: GELS), a clinical and science-based developer of gel-based oral delivery solutions, welcomes the recently announced product launches of Healthy Extracts, Inc. (“Healthy Extracts,” OTCQB: HYEX), whose products apply Gelteq's proprietary gel technology, into the U.S. nutraceutical market.
Gelteq Technology Powers U.S. Product Launches of its Nutraceutical Products for Partner
Neutral
GlobeNewsWire
3 months ago
Gelteq Announces Commencement of Preclinical Trial for Novel Gel-Based Antihistamine Formulation Targeting Allergy Market
MELBOURNE, Australia, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”), a clinical and science-based company specialising in gel-based oral delivery solutions, today announced plans to commence a preclinical bioequivalence study in September 2025 to evaluate its novel gel-based formulation of a widely used antihistamine for allergy treatment.
Gelteq Announces Commencement of Preclinical Trial for Novel Gel-Based Antihistamine Formulation Targeting Allergy Market
Neutral
Accesswire
3 months ago
Healthy Extracts Builds Upon Record Q2 Results and Transformative Merger with Launch of New Revolutionary Hydration and Sugar Metabolism Gel-Packs
Hydrate EZ™ delivers rapid hydration and essential electrolytes for staying refreshed, sharp and in control. Mynus Sugar™ is clinically formulated to support healthy carbohydrate metabolism.
Healthy Extracts Builds Upon Record Q2 Results and Transformative Merger with Launch of New Revolutionary Hydration and Sugar Metabolism Gel-Packs